DNL-747

N/A

Report date: 2024/12/05 20:00:05
NME

Base Information

Drug NameDNL-747
Drug Alias NameSAR-443060DNL-747
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiDenali Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A